Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene

J Clin Psychopharmacol. 2000 Feb;20(1):105-7. doi: 10.1097/00004714-200002000-00021.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Analysis of Variance
  • Carrier Proteins / genetics*
  • Depressive Disorder, Major / blood
  • Depressive Disorder, Major / genetics*
  • Female
  • Genotype
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Membrane Transport Proteins*
  • Middle Aged
  • Nerve Tissue Proteins*
  • Paroxetine / blood
  • Polymorphism, Genetic*
  • Selective Serotonin Reuptake Inhibitors / blood
  • Serotonin Plasma Membrane Transport Proteins
  • Single-Blind Method

Substances

  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Paroxetine